Cheryl Silberman

915 total citations
10 papers, 736 citations indexed

About

Cheryl Silberman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cheryl Silberman has authored 10 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cheryl Silberman's work include Diabetes Management and Research (3 papers), Cancer survivorship and care (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Cheryl Silberman is often cited by papers focused on Diabetes Management and Research (3 papers), Cancer survivorship and care (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Cheryl Silberman collaborates with scholars based in United States, United Kingdom and Brazil. Cheryl Silberman's co-authors include Eva Lydick, David Cella, David T. Eton, Anne Heyes, Myles Wolf, David A. Johnson, P. Bonomi, Diane L. Fairclough, Edward S. Horton and Keith L. Davis and has published in prestigious journals such as Diabetes Care, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Cheryl Silberman

10 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl Silberman United States	7	280	250	164	97	96	10	736
Marisa A. Bittoni United States	15	235 0.8×	452 1.8×	116 0.7×	100 1.0×	83 0.9×	37	868
Christiane Voisin United States	12	373 1.3×	137 0.5×	80 0.5×	165 1.7×	96 1.0×	41	911
Libby Black United States	19	586 2.1×	132 0.5×	140 0.9×	85 0.9×	49 0.5×	52	1.2k
Flora A. Ukoli United States	21	319 1.1×	230 0.9×	250 1.5×	92 0.9×	236 2.5×	50	1.3k
Allison Freeman United States	8	94 0.3×	142 0.6×	165 1.0×	84 0.9×	48 0.5×	9	905
Vibeke R. Gerkins United States	8	117 0.4×	307 1.2×	316 1.9×	54 0.6×	128 1.3×	9	1.2k
Susan Olivo‐Marston United States	15	279 1.0×	298 1.2×	57 0.3×	70 0.7×	89 0.9×	29	1.0k
Issei Kurahashi Japan	18	216 0.8×	160 0.6×	149 0.9×	157 1.6×	99 1.0×	36	1.0k
G. J. van Londen United States	18	190 0.7×	449 1.8×	66 0.4×	42 0.4×	132 1.4×	44	845
Jacob Franek Canada	13	206 0.7×	117 0.5×	57 0.3×	168 1.7×	64 0.7×	16	683

Countries citing papers authored by Cheryl Silberman

Since Specialization

Citations

This map shows the geographic impact of Cheryl Silberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Silberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Silberman more than expected).

Fields of papers citing papers by Cheryl Silberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Silberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Silberman. The network helps show where Cheryl Silberman may publish in the future.

Co-authorship network of co-authors of Cheryl Silberman

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Silberman. A scholar is included among the top collaborators of Cheryl Silberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Silberman. Cheryl Silberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Horton, Edward S., Cheryl Silberman, Keith L. Davis, & Rachele Berria. (2010). Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database. Diabetes Care. 33(8). 1759–1765. 133 indexed citations

Valentine, William J., Daniel Tucker, Cheryl Silberman, et al.. (2008). Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive. Value in Health. 12(1). 1–9. 13 indexed citations

Landschulz, William, et al.. (2006). The Art of Health Promotion. American Journal of Health Promotion. 21(1). TAHP–1. 5 indexed citations

Yost, Kathleen J., et al.. (2005). Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI). Breast Cancer Research and Treatment. 90(3). 295–298. 20 indexed citations

Cella, David, et al.. (2002). The Validity and Clinical Utility of Symptom Monitoring in Advanced Lung Cancer: A Literature Review. Clinical Lung Cancer. 4(3). 153–160. 18 indexed citations

Cella, David, David T. Eton, Diane L. Fairclough, et al.. (2002). What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. Journal of Clinical Epidemiology. 55(3). 285–295. 321 indexed citations

Silberman, Cheryl, et al.. (2002). Interpretation of quality-of-life data from a clinician's point of view: Getting to the clinical part of clinically meaningful change. Clinical Therapeutics. 24. 40–41. 1 indexed citations

Erbey, John R., Cheryl Silberman, & Eva Lydick. (2000). Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. The American Journal of Medicine. 109(7). 588–590. 70 indexed citations

Stang, Paul, et al.. (2000). The Prevalence of COPD. CHEST Journal. 117(5). 354S–359S. 152 indexed citations

10.

Silberman, Cheryl, et al.. (1965). Apparition de leucemies chez des souris c57bl apres greffe d'organes normaux isologues.. Bulletin of the World Health Organization. 40(5). 63–83. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact